Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
How I treat hemochromatosis Adams PC; Barton JCBlood 2010[Jul]; 116 (3): 317-25Hemochromatosis is a common genetic disorder in which iron may progressively accumulate in the liver, heart, and other organs. The primary goal of therapy is iron depletion to normalize body iron stores and to prevent or decrease organ dysfunction. The primary therapy to normalize iron stores is phlebotomy. In this opinion article, we discuss the indications for and monitoring of phlebotomy therapy to achieve iron depletion, maintenance therapy, dietary and pharmacologic maneuvers that could reduce iron absorption, and the role of voluntary blood donation.|*Phlebotomy[MESH]|Blood Donors[MESH]|Chelation Therapy[MESH]|Cytapheresis[MESH]|Deferoxamine/therapeutic use[MESH]|Female[MESH]|Hemochromatosis Protein[MESH]|Hemochromatosis/genetics/metabolism/*therapy[MESH]|Histocompatibility Antigens Class I/genetics[MESH]|Homozygote[MESH]|Humans[MESH]|Iron, Dietary/administration & dosage[MESH]|Iron/metabolism[MESH]|Male[MESH]|Membrane Proteins/genetics[MESH]|Proton Pump Inhibitors/therapeutic use[MESH]|Siderophores/therapeutic use[MESH] |
